INMUNE BIO INC. Operating Lease Right-of-Use Assets
INMUNE BIO INC. (INMB) had Operating Lease Right-of-Use Assets of $1.25 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $1.25M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $1.41M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $914.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.06M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.41M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $914.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.06M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $374.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $278.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $307.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $335.00K 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $363.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $389.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $414.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $444.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $468.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $485.00K 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $507.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $529.00K 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $650.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $681.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $726.00K 10-K · filed 2023-03-02 | $137.00K 10-Q · filed 2021-08-04 |
| 2021-09-30 | $128.00K 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $137.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $147.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $156.00K 10-K · filed 2022-03-03 | $156.21K 10-K · filed 2021-03-04 |
| 2020-09-30 | $165.39K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $174.65K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $182.68K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $191.54K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $199.22K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $209.23K 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |